Literature DB >> 196632

Selective inhibition of cyclic nucleotide phosphodiesterases by analogues of 1-methyl-3-isobutylxanthine.

G L Kramer, J E Garst, S S Mitchel, J N Wells.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 196632     DOI： 10.1021/bi00634a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  6 in total

Review 1.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

2.  Strategic approaches to drug design. II. Modelling studies on phosphodiesterase substrates and inhibitors.

Authors:  A Davis; B H Warrington; J G Vinter
Journal:  J Comput Aided Mol Des       Date:  1987-07       Impact factor: 3.686

3.  Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase.

Authors:  A Beretz; R Anton; J C Stoclet
Journal:  Experientia       Date:  1978-08-15

4.  Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP.

Authors:  N Kawada; T Kuroki; K Kobayashi; M Inoue; K Kaneda
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

5.  The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors.

Authors:  D Salvemini; W Radziszewski; R Korbut; J Vane
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

6.  Stimulation of electro-olfactogram responses in the main olfactory epithelia by airflow depends on the type 3 adenylyl cyclase.

Authors:  Xuanmao Chen; Zhengui Xia; Daniel R Storm
Journal:  J Neurosci       Date:  2012-11-07       Impact factor: 6.167
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.